Foresite Capital Management IV, LLC: 13F holdings
CIK 17041322026Q2
| Positions | 6 |
|---|
| Reported value | $290.2m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 6 (-2 vs prior quarter) |
|---|
| Reported value | $290.2m (+22.4%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| Pharvaris N.V. | 4,778,581 | $165.2m | 57.0% |
| CYTK CYTOKINETICS INC | 714,695 | $60.9m | 21.0% |
| Eikon Therapeutics, Inc. | 1,943,682 | $25.4m | 8.7% |
| RLAY Relay Therapeutics, Inc. | 1,250,000 | $23.4m | 8.1% |
| XENE Xenon Pharmaceuticals Inc. | 160,000 | $9.7m | 3.3% |
| Crinetics Pharmaceuticals, Inc. | 150,000 | $5.6m | 1.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1704132")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples